INS and early-onset autosomal dominant Alzheimer disease: The impairments in glucose metabolism, insulin signalling, insulin sensitivity and lipid metabolism, as well as increases in inflammation and oxidative stress in central nerve and peripheral system, contribute to the risk of Alzheimer’s disease (AD) [249,250,251,252].